Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells
- PMID: 8755507
- PMCID: PMC38778
- DOI: 10.1073/pnas.93.15.7522
Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells
Abstract
The host range of retroviral oncogenes is naturally limited by the host range of the retroviral vector. The question of whether the transforming host range of retroviral oncogenes is also restricted by the host species has not been directly addressed. Here we have tested in avian and murine host species the transforming host range of two retroviral onc genes, myc of avian carcinoma viruses MH2 and MC29 and mht/raf of avian carcinoma virus MH2 and murine sarcoma virus MSV 3611. Virus vector-mediated host restriction was bypassed by recombining viral oncogenes with retroviral vectors that can readily infect the host to be tested. It was found that, despite high expression, transforming function of retroviral myc genes is restricted to avian cells, and that of retroviral mht/raf genes is restricted to murine cells. Since retroviral oncogenes encode the same proteins as certain cellular genes, termed protooncogenes, our data must also be relevant to the oncogene hypothesis of cancer. According to this hypothesis, cancer is caused by mutation of protooncogenes. Because protooncogenes are conserved in evolution and are presumed to have conserved functions, the oncogene hypothesis assumes no host range restriction of transforming function. For example, mutated human proto-myc is postulated to cause Burkitt lymphoma, because avian retroviruses with myc genes cause cancer in birds. But there is no evidence that known mutated protooncogenes can transform human cells. The findings reported here indicate that host range restriction appears to be one of the reasons (in addition to insufficient transcriptional activation) why known, mutated protooncogenes lack transforming function in human cells.
Similar articles
-
Nucleotide sequence of avian carcinoma virus MH2: two potential onc genes, one related to avian virus MC29 and the other related to murine sarcoma virus 3611.Proc Natl Acad Sci U S A. 1984 May;81(10):3000-4. doi: 10.1073/pnas.81.10.3000. Proc Natl Acad Sci U S A. 1984. PMID: 6328485 Free PMC article.
-
Two oncogenes in avian carcinoma virus MH2: myc and mht.Anticancer Res. 1985 Jan-Feb;5(1):73-9. Anticancer Res. 1985. PMID: 2986522
-
Nucleotide sequence of avian retroviral oncogene v-mil: homologue of murine retroviral oncogene v-raf.Nature. 1984 May 3-9;309(5963):85-8. doi: 10.1038/309085a0. Nature. 1984. PMID: 6325930
-
Cancer genes: rare recombinants instead of activated oncogenes (a review).Proc Natl Acad Sci U S A. 1987 Apr;84(8):2117-24. doi: 10.1073/pnas.84.8.2117. Proc Natl Acad Sci U S A. 1987. PMID: 3550807 Free PMC article. Review.
-
Oncogenes in retroviruses and cells: biochemistry and molecular genetics.Adv Cancer Res. 1986;47:99-188. doi: 10.1016/s0065-230x(08)60199-2. Adv Cancer Res. 1986. PMID: 3022566 Review. No abstract available.
Cited by
-
Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers.Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9614-9. doi: 10.1073/pnas.94.18.9614. Proc Natl Acad Sci U S A. 1997. PMID: 9275171 Free PMC article.
-
Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein.Int J Cancer. 2009 Oct 1;125(7):1558-65. doi: 10.1002/ijc.24449. Int J Cancer. 2009. PMID: 19444914 Free PMC article.
-
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.Mol Biol Cell. 1999 Jun;10(6):1693-703. doi: 10.1091/mbc.10.6.1693. Mol Biol Cell. 1999. PMID: 10359590 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous